This video article describes a modified in vitro method to examine the role of hormones, cytokines and/or growth factors in driving cancer cell invasion.
A subscription to JoVE is required to view this content. Sign in or start your free trial.
Method Article
* These authors contributed equally
This video article describes a modified in vitro method to examine the role of hormones, cytokines and/or growth factors in driving cancer cell invasion.
Blood serum serves as a chemoattractant towards which cancer cells migrate and invade, facilitating their intravasation into microvessels. However, the actual molecules towards which the cells migrate remain elusive. This modified invasion assay has been developed to identify targets which drive cell migration and invasion. This technique compares the invasion index under three conditions to determine whether a specific hormone, growth factor, or cytokine plays a role in mediating the invasive potential of a cancer cell. These conditions include i) normal fetal bovine serum (FBS), ii) charcoal-stripped FBS (CS-FBS), which removes hormones, growth factors, and cytokines and iii) CS-FBS + molecule (denoted “X”). A significant change in cell invasion with CS-FBS as compared to FBS, indicates the involvement of hormones, cytokines or growth factors in mediating the change. Individual molecules can then be added back to CS-FBS to assay their ability to reverse or rescue the invasion phenotype. Furthermore, two or more factors can be combined to evaluate the additive or synergistic effects of multiple molecules in driving or inhibiting invasion. Overall, this method enables the investigator to determine whether hormones, cytokines, and/or growth factors play a role in cell invasion by serving as chemoattractants or inhibitors of invasion for a particular type of cancer cell or a specific mutant. By identifying specific chemoattractants and inhibitors, this modified invasion assay may help to elucidate signaling pathways that direct cancer cell invasion.
A novel invasion assay has been developed with the goal of identifying the involvement of specific hormones, cytokines and/or growth factors as chemoattractants in cancer cell invasion. The ability of tumor cells to invade through the extracellular matrix (ECM) is a hallmark of the metastatic phenotype1-3. Invasion chambers have been extensively used as in vitro tools to study cancer cell invasion and migration and may provide knowledge as to the mechanisms of in vivo tumor invasion and metastasis. The chambers consist of cylindrical cell culture inserts nested within the wells of cell culture plates. The bottoms of the inserts ar....
Access restricted. Please log in or start a trial to view this content.
1. Prepare the Different Media and Additional Components
2. Prepare the Collagen Matrix on Ice
Access restricted. Please log in or start a trial to view this content.
The invasion index is calculated for each condition according to normalization to a noninvasive cell line. For our experiments, we use the 1205Lu melanoma cell line and established variant stable cell lines as our invasive lines as well as the premalignant noninvasive variant, WM793 from which the 1205Lu cells were derived10 which serves as a logical control. We also utilize collagen I as the invasion matrix because that is the primary component of the dermis. This is in accordance with a previous study whereb.......
Access restricted. Please log in or start a trial to view this content.
Tumor metastasis is a multistep process. The cells must break through the basement membrane, intravasate into either the lymphatic system or blood microvessels, in which they are transported to distant sites. The tumor cells then extravasate and colonize into a macrometastasis12. Progression through the epithelial to mesenchymal transition (EMT), tumor invasion, and metastasis has been enhanced by steroid hormones13,14, growth factors15-18, and cytokines19-21. These molecules a.......
Access restricted. Please log in or start a trial to view this content.
The authors have nothing to disclose.
The authors acknowledge funding sources from D’Youville College School of Pharmacy, Buffalo, NY.
....Access restricted. Please log in or start a trial to view this content.
| Name | Company | Catalog Number | Comments |
|---|---|---|---|
| BioCoat Control Inserts with 8.0 µm PET membrane | Corning | 354578 | 12 in each of two 24-well plates. PET = polyethylene teraphthalate |
| Collagen I, rat tail | Corning | 354236 | Source = rat tail tendon, purity = 90% |
| Fixative; Diff-Quick | Thermo Fisher Scientific | NC9844047 | Methanol-based fixative, hematoxylin/eosin |
| Fetal bovine serum | Life Technologies | 16000 | Designated as FBS |
| Charcoal stripped fetal bovine serum | Life Technologies | 12676 | Designated as CS-FBS |
| Fetal bovine serum | Thermo Scientific Hyclone | SH30070 | Designated as FBS |
| Charcoal stripped fetal bovine serum | Thermo Scientific Hyclone | SH30068 | Designated as CS-FBS |
Access restricted. Please log in or start a trial to view this content.